Antipsychotic use in pregnancy. What are the best treatment options?

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Both the rapid emergence of new antipsychotic medications and the increasing fertility rate among women with psychotic disorders have contributed to the growing clinical importance of the treatment of pregnant women who have psychotic illnesses. The treatment of this patient population must always take into consideration the effect of that treatment on the fetus. With regard to the high risk of decompensation during pregnancy and postpartum, continuous antipsychotic medication is needed using the minimum effective dose. The use of high-potency agents appears to be preferable for first-line management, as there are few data regarding the use of atypical agents such as clozapine in pregnancy. Guidelines for treating pregnant women with psychoses vary little from those for nonpregnant patients. Clinicians must always carefully weigh up the risks and benefits for each patient on an individual basis.

Original languageEnglish
Pages (from-to)403-410
Number of pages8
JournalDrug Safety
Volume16
Issue number6
Publication statusPublished - 1997

Fingerprint

Antipsychotic Agents
Pregnancy
Psychotic Disorders
Pregnant Women
Clozapine
Birth Rate
Postpartum Period
Fetus
Therapeutics
Guidelines
Population

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Pharmacology
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Antipsychotic use in pregnancy. What are the best treatment options? / Trixler, M.; Tényi, T.

In: Drug Safety, Vol. 16, No. 6, 1997, p. 403-410.

Research output: Contribution to journalArticle

@article{cdc10f919a1045779bf602e45f1c9dd2,
title = "Antipsychotic use in pregnancy. What are the best treatment options?",
abstract = "Both the rapid emergence of new antipsychotic medications and the increasing fertility rate among women with psychotic disorders have contributed to the growing clinical importance of the treatment of pregnant women who have psychotic illnesses. The treatment of this patient population must always take into consideration the effect of that treatment on the fetus. With regard to the high risk of decompensation during pregnancy and postpartum, continuous antipsychotic medication is needed using the minimum effective dose. The use of high-potency agents appears to be preferable for first-line management, as there are few data regarding the use of atypical agents such as clozapine in pregnancy. Guidelines for treating pregnant women with psychoses vary little from those for nonpregnant patients. Clinicians must always carefully weigh up the risks and benefits for each patient on an individual basis.",
author = "M. Trixler and T. T{\'e}nyi",
year = "1997",
language = "English",
volume = "16",
pages = "403--410",
journal = "Drug Safety",
issn = "0114-5916",
publisher = "Adis International Ltd",
number = "6",

}

TY - JOUR

T1 - Antipsychotic use in pregnancy. What are the best treatment options?

AU - Trixler, M.

AU - Tényi, T.

PY - 1997

Y1 - 1997

N2 - Both the rapid emergence of new antipsychotic medications and the increasing fertility rate among women with psychotic disorders have contributed to the growing clinical importance of the treatment of pregnant women who have psychotic illnesses. The treatment of this patient population must always take into consideration the effect of that treatment on the fetus. With regard to the high risk of decompensation during pregnancy and postpartum, continuous antipsychotic medication is needed using the minimum effective dose. The use of high-potency agents appears to be preferable for first-line management, as there are few data regarding the use of atypical agents such as clozapine in pregnancy. Guidelines for treating pregnant women with psychoses vary little from those for nonpregnant patients. Clinicians must always carefully weigh up the risks and benefits for each patient on an individual basis.

AB - Both the rapid emergence of new antipsychotic medications and the increasing fertility rate among women with psychotic disorders have contributed to the growing clinical importance of the treatment of pregnant women who have psychotic illnesses. The treatment of this patient population must always take into consideration the effect of that treatment on the fetus. With regard to the high risk of decompensation during pregnancy and postpartum, continuous antipsychotic medication is needed using the minimum effective dose. The use of high-potency agents appears to be preferable for first-line management, as there are few data regarding the use of atypical agents such as clozapine in pregnancy. Guidelines for treating pregnant women with psychoses vary little from those for nonpregnant patients. Clinicians must always carefully weigh up the risks and benefits for each patient on an individual basis.

UR - http://www.scopus.com/inward/record.url?scp=0030741337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030741337&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 403

EP - 410

JO - Drug Safety

JF - Drug Safety

SN - 0114-5916

IS - 6

ER -